Pamidronate (Aredia)

DRUG2 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University Hospital, Basel, Switzerland

Conditions

Heterotopic OssificationOsteogenesis Imperfecta

Phase 3

Pamidronate to Treat Osteogenesis Imperfecta in Children

CompletedNCT00005901

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Osteogenesis Imperfecta

Start: 2000-06-30End: 2015-03-31Updated: 2016-03-01

Unknown Phase

Study of Pamidronate for the Prevention of Heterotopic Ossification

WithdrawnNCT00262392

University Hospital, Basel, SwitzerlandHeterotopic Ossification

Start: 2005-06-30End: 2010-06-30Updated: 2015-03-10